solufenum

Known as: lysine-p-isobutylphenylpropionate, Ibuprofen Lysine, L-lysine, mono(alpha-methyl-4-(2-methylpropyl)benzeneacetate) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Patent ductus arteriosus (PDA) is a common clinical condition in preterm infants. Preterm newborns with PDA are at greater risk… (More)
  • figure 1
Is this relevant?
2009
2009
ObjectiveIbuprofen might have advantages over indomethacin, when used to effectuate closure of a neonate's patent ductus… (More)
  • table 1
  • figure 2
  • figure 1
Is this relevant?
2007
2007
Patent ductus arteriosus (PDA) affects approximately 31% of infants whose birth weight is between 501 and 1500 g. The ductus… (More)
Is this relevant?
2003
2003
BACKGROUND Patent ductus arteriosus (PDA) is commonly found in very low-birthweight (VLBW) infants. The presence of respiratory… (More)
Is this relevant?
2002
2002
PURPOSE To investigate the ocular pharmacodynamic profile of a polymer nanoparticle system loaded with sodium ibuprofen (IBU-RS… (More)
Is this relevant?
2000
2000
This study was aimed at evaluating the efficacy of ibuprofen in the prophylaxis of patent ductus arteriosus (PDA) in very preterm… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1996
Highly Cited
1996
OBJECTIVE To test whether early postnatal (0 to 3 hours) intravenous administration of ibuprofen will prevent patent ductus… (More)
Is this relevant?
1995
1995
This single-dose, double-blind, parallel-group, single-site study compared ibuprofen lysine 400 mg with acetaminophen 1000 mg and… (More)
Is this relevant?
1990
1990
The lysine salt of d,l-2-(4-isobutylphenyl)-propionic acid (ibuprofen lysine) was administered as a single oral dose of 500 mg by… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1989
1989
The pharmacokinetic properties of ibuprofen p.o. given either as a lysine salt or as acid to eight young, healthy male volunteers… (More)
Is this relevant?